Mr. Trudnak holds more than 25 years of proven experience in leading small- to large-scale organizations and developing top-tier global teams. He proved his resourcefulness and problem-solving skillset early in his career when he served as the ground-floor IT executive during a $500 million acquisition by a Fortune 500 company (Siebel Systems) of his then-employer, OpenSite, Inc.

One of his first forays into the realm of clinical research was with Clinipace, a provider of integrated software solutions for CRO clients. The company’s flagship solution, TEMPO, worked to integrate a CRO’s data and tools onto a single platform—a groundbreaking concept at the time. After the company decided to become a CRO itself, Mr. Trudnak created the technical strategy, reimagined the company’s IT infrastructure, and implemented the technical capabilities and functions necessary for essential clinical research operations.

What followed was a period of exponential growth for the company, during which Mr. Trudnak oversaw the IT integration of six multi-national acquisitions over a seven-year period.  By the time he had accepted a position at VeraSci as VP of Technology & Infrastructure, Clinipace was an efficient and technology-enabled global CRO with operations spanning 38 countries and a workforce of 1,000+ employees. He also helped navigate the company’s growth from $1 million to $120 million in annual revenue.

With more than 20 years in the clinical research industry and providing security and compliance consultation services to life science companies, Mr. Trudnak partnered with various CROs, including CRC, as an IT consultant before joining CRC full time as Chief Information Officer in November of 2022.

When not charting plans for success, Mr. Trudnak enjoys reading, long walks with his dog, playing guitar, and spending time with his wife, kids, and grandchildren.